Clinical application of capreomycin in pulmonary tuberculosis.
D000328:Adult; D000419:Albuminuria / Q000139:chemically induced; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D004802:Eosinophilia / Q000139:chemically induced; D004977:Ethambutol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D004977:Ethambutol